跳至主要内容
临床试验/NCT05551052
NCT05551052进行中(未招募)不适用

Prospective, Multi-center Observational Study for the Clinical Validation of the Next Generation Test for Blood-based Screening of Colorectal Cancer

New Day Diagnostics3 个研究点 分布在 1 个国家目标入组 196 人开始时间: 2022年9月8日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
196
试验地点
3
主要终点
Specificity for CRC of the Next-Gen CRC Screening Test

研究概览

简要总结

The CRC DRAW study will assess the sensitivity and specificity of the blood-based, Next-Gen CRC Screening Test for the detection of CRC.

详细描述

The CRC DRAW study is a prospective, multi-center, observational study to validate the Next-Gen CRC Screening test for the detection of CRC. The study will collect blood samples from average-risk participants scheduled for screening colonoscopies.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
45 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participant is 45 years of age or older at time of enrollment.
  • Participant is at average risk for development of colorectal cancer (as defined by inclusion and exclusion criteria)
  • Participant is able and willing to undergo a screening colonoscopy
  • Participant is able and willing to sign informed consent and adhere to study requirements
  • Participant is able to provide blood sample prior to colonoscopy (within 90 days of scheduled colonoscopy).

排除标准

  • Previous personal history of CRC or precancerous lesions
  • Positive result from non-invasive screening test within the associated recommended intervals:
  • 2.1 Fecal occult blood test or fecal immunochemical test within the previous 12 months 2.2 Epi proColon test within the previous 12 months 2.3 FIT-DNA (Cologuard) test within the previous 36 months
  • Diagnosed with condition associated with higher risk for colorectal cancer, such as:
  • 3.1 Inflammatory bowel disease (IBD) 3.2 Chronic ulcerative colitis (CUC) 3.3 Crohn's disease 3.4 Familial adenomatous polyposis (FAP) 3.5 Familial history for colorectal cancer 3.5.1 One or more first-degree relatives diagnosed with CRC or adenomatous polyps before 60 years of age 3.5.2 Two or more first degree relatives diagnosed at any age with CRC
  • Individuals with relevant familial (hereditary) cancer syndrome, such as:
  • 4.1 Hereditary non-polyposis colorectal cancer syndrome (HNPCC or Lynch Syndrome) 4.2 Peutz-Jeghers Syndrome 4.3 MYH-Associated Polyposis (MAP) 4.4 Gardner's syndrome 4.5Turcot's (or Crail's) syndrome 4.6 Cowden's syndrome, 4.7Juvenile Polyposis 4.8 Cronkhite-Canada syndrome 4.9 Neurofibromatosis 4.10 Familial Hyperplastic Polyposis
  • Diagnosed with chronic gastritis or cirrhosis
  • Current diagnosis of any cancer, except non-melanoma skin cancer
  • Overt rectal bleeding or bleeding hemorrhoids within previous 30 days
  • A colonoscopy within the previous 9 years, with the exception of a failed colonoscopy due to poor bowel preparation

结局指标

主要结局

Specificity for CRC of the Next-Gen CRC Screening Test

时间窗: blood collection up to 90 days from colonoscopy

Clinical Performance

Sensitivity for CRC of the Next-Gen CRC Screening Test

时间窗: blood collection up to 90 days from colonoscopy

Clinical Performance

次要结局

  • Sensitivity for advanced precancerous lesions of the Next-Gen CRC Screening Test(blood collection up to 90 days from colonoscopy)
  • Specificity for no colorectal neoplastic findings of the Next-Gen CRC Screening Test(blood collection up to 90 days from colonoscopy)

研究者

申办方类型
Network
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验